-
公开(公告)号：US10314915B2
公开(公告)日：2019-06-11
申请号：US14437626
申请日：2013-11-26
Applicant: AMOREPACIFIC CORPORATION
Inventor： Jeong Ah Hwang , Yu Jin Oh , Young Kyung Kim , Jin Oh Chung , Sang Jun Lee , Soon Mi Shim , Jae Hwan Chung
IPC: A61K31/047 , A61K31/375 , A61K9/00 , A61K9/16 , A61K9/20 , A23L29/30 , A61K31/00 , A61K36/82 , A61K47/40 , A61K47/69 , A23L33/105 , A61K31/185 , A61K31/194 , A61K31/353
Abstract: Disclosed is a catechin bioavailability enhancer comprising cyclodextrin as an active ingredient. Further, disclosed is a composition comprising a catechin bioavailability enhancer comprising catechin and cyclodextrin. The composition disclosed in the present specification may improve the stability of catechin which has significantly low intestinal absorption rate, and thus may improve bioaccessibility, intestinal transport rate and bioavailability of catechin. Accordingly, the improved bioavailability may further increase the effects of catechin such as the effects of reducing weight and body fat, anti-oxidative effects and anti-aging effects. The composition disclosed in the present specification having the abovementioned characteristics can be effectively used in the fields of food or pharmacy.
-
公开(公告)号：US10022351B2
公开(公告)日：2018-07-17
申请号：US15160239
申请日：2016-05-20
Applicant: AMOREPACIFIC CORPORATION
Inventor： Byung Gyu Kim , Hyun Woo Jeong , Su Kyung Kim , Si Young Cho , Chan Woong Park , Dae Bang Seo , Wan Gi Kim , Sang Jun Lee
IPC: A61K31/34 , A23L2/52 , A61K36/258 , A23L33/11 , A23L33/105
Abstract: The present invention relates to a compound of Formula 1, and an SIRT 1 activator including, as an active ingredient, derivatives thereof or pharmaceutically acceptable salts thereof. The present invention also relates to a composition including the SIRT 1 activator for detoxification, for the improvement of metabolic disorders, for the prevention or improvement of eye diseases, or the prevention or improvement of immune diseases.
-
公开(公告)号：US09999611B2
公开(公告)日：2018-06-19
申请号：US15160197
申请日：2016-05-20
Applicant: AMOREPACIFIC CORPORATION
Inventor： Byung Gyu Kim , Hyun Woo Jeong , Su Kyung Kim , Si Young Cho , Chan Woong Park , Dae Bang Seo , Wan Gi Kim , Sang Jun Lee
IPC: A61K31/34 , A23L2/52 , A61K36/258 , A23L33/11 , A23L33/105
CPC classification number: A61K31/34 , A23L2/52 , A23L33/105 , A23L33/11 , A23V2002/00 , A61K36/258
Abstract: The present invention relates to a compound of Formula 1, and an SIRT 1 activator including, as an active ingredient, derivatives thereof or pharmaceutically acceptable salts thereof. The present invention also relates to a composition including the SIRT 1 activator for detoxification, for the improvement of metabolic disorders, for the prevention or improvement of eye diseases, or the prevention or improvement of immune diseases.
-
公开(公告)号：US09913823B2
公开(公告)日：2018-03-13
申请号：US14352444
申请日：2012-10-18
Applicant: AMOREPACIFIC CORPORATION
Inventor： Byung Gyu Kim , Hyun Woo Jeong , Su Kyung Kim , Si Young Cho , Chan Woong Park , Dae Bang Seo , Wan Gi Kim , Sang Jun Lee
IPC: A61K31/34 , A23L1/30 , A61K36/258 , A23L33/11 , A23L2/52 , A23L33/105
CPC classification number: A61K31/34 , A23L2/52 , A23L33/105 , A23L33/11 , A23V2002/00 , A61K36/258
Abstract: The present invention relates to a compound of Formula 1, and an SIRT 1 activator including, as an active ingredient, derivatives thereof or pharmaceutically acceptable salts thereof. The present invention also relates to a composition including the SIRT 1 activator for detoxification, for the improvement of metabolic disorders, for the prevention or improvement of eye diseases, or the prevention or improvement of immune diseases.
-
Patent Agency Ranking
公开(公告)号：US09795583B2
公开(公告)日：2017-10-24
申请号：US14437802
申请日：2013-11-29
Applicant: AMOREPACIFIC CORPORATION
Inventor： Si Young Cho , Dae Bang Seo , Chan Woong Park , Wan Gi Kim , Sang Jun Lee
CPC classification number: A61K31/34 , A23L33/10 , A23V2002/00 , A61K31/05 , A61K31/36
Abstract: The present invention relates to a composition for preventing or treating heart disease, and more particularly, to a composition for preventing or treating heart disease, comprising (+)-syringaresinol. Specifically, (+)-syringaresinol as an active ingredient may exhibit excellent effect of preventing or improving heart disease by promoting SIRT1 expression and suppressing death of cardiomyocytes induced by reactive oxygen species. Accordingly, the composition according to the present disclosure may be used to prevent, improve or treat heart diseases including cardiovascular diseases.
-
公开(公告)号：US09474706B2
公开(公告)日：2016-10-25
申请号：US14771372
申请日：2014-02-27
Applicant: AMOREPACIFIC CORPORATION
Inventor： Hyun Jung Shin , Jin Kyu Choi , Byung Gyu Kim , Dae Bang Seo , Sang Jun Lee
CPC classification number: A61K8/65 , A23L33/18 , A23V2002/00 , A61K8/735 , A61K9/0095 , A61K9/2059 , A61K9/4875 , A61K31/728 , A61K36/258 , A61K38/005 , A61K38/06 , A61K38/39 , A61K2800/91 , A61Q19/00 , A61Q19/08 , A61K2300/00
Abstract: The present invention relates to a composition for maintaining efficacy of a filler for a long period of time by containing collagen as an active ingredient. The composition according to the present invention is useful since the composition can promote the synthesis of hyaluronic acid and inhibit activity of hyaluronidase, thereby maintaining the efficacy of a hyaluronic acid filler for a longer period of time. Therefore, even with less number of times of filler injection, the efficacy of the filler can be maintained and skin irritation can be also reduced.
Abstract translation: 本发明涉及通过含有胶原作为有效成分来长期维持填充剂的功效的组合物。 根据本发明的组合物是有用的，因为组合物可以促进透明质酸的合成并抑制透明质酸酶的活性，从而保持透明质酸填充剂的更长时间的功效。 因此，即使填充剂注射次数较少，也可以保持填充剂的功效，并且还可以减少皮肤刺激。
-
公开(公告)号：US09192597B2
公开(公告)日：2015-11-24
申请号：US14350668
申请日：2012-10-25
Applicant: AMOREPACIFIC CORPORATION
Inventor： Si Young Cho , Chan Woong Park , Dae Bang Seo , Wan Gi Kim , Sang Jun Lee
IPC: A01N65/00 , A61K31/34 , A61K36/00 , A23L1/30 , A61K36/258 , A61K9/00 , A61K9/16 , A61K9/20 , A61K36/185 , A61K36/254 , A61K36/55 , A61K36/756
CPC classification number: A61K31/34 , A23L33/105 , A23V2002/00 , A61K9/0014 , A61K9/0053 , A61K9/0095 , A61K9/1652 , A61K9/2059 , A61K36/00 , A61K36/185 , A61K36/254 , A61K36/258 , A61K36/55 , A61K36/756 , A23V2200/302 , A23V2200/326 , A23V2250/21
Abstract: The present invention discloses a composition for inhibiting vascular aging comprising a compound of Chemical formula 1, a derivative thereof or a pharmaceutically acceptable salt thereof as an active ingredient.
Abstract translation: 本发明公开了一种用于抑制血管衰老的组合物，其包含化学式1的化合物，其衍生物或其药学上可接受的盐作为活性成分。
-
公开(公告)号：US20140371307A1
公开(公告)日：2014-12-18
申请号：US14352444
申请日：2012-10-18
Applicant: AMOREPACIFIC CORPORATION
Inventor： Byung Gyu Kim , Hyun Woo Jeong , Su Kyung Kim , Si Young Cho , Chan Woong Park , Dae Bang Seo , Wan Gi Kim , Sang Jun Lee
IPC: A61K31/34 , A23L1/30 , A61K36/258
CPC classification number: A61K31/34 , A23L2/52 , A23L33/105 , A23L33/11 , A23V2002/00 , A61K36/258
Abstract: The present invention relates to a compound of Formula 1, and an SIRT 1 activator including, as an active ingredient, derivatives thereof or pharmaceutically acceptable salts thereof. The present invention also relates to a composition including the SIRT 1 activator for detoxification, for the improvement of metabolic disorders, for the prevention or improvement of eye diseases, or the prevention or improvement of immune diseases.
Abstract translation: 本发明涉及式1化合物和SIRT 1活化剂，其包括其衍生物或其药学上可接受的盐作为活性成分。 本发明还涉及包含用于解毒的SIRT1激活剂，用于改善代谢紊乱，用于预防或改善眼部疾病或预防或改善免疫疾病的组合物。
-
29.发明申请COMPOSITION FOR INHIBITING VASCULAR AGING COMPRISING SYRINGARESINOL 有权用于抑制包含SYRINGARESINOL的血管平滑肌的组合物公开(公告)号：US20140248381A1
公开(公告)日：2014-09-04
申请号：US14350668
申请日：2012-10-25
Applicant: AMOREPACIFIC CORPORATION
Inventor： Si Young Cho , Chan Woong Park , Dae Bang Seo , Wan Gi Kim , Sang Jun Lee
IPC: A61K31/34 , A61K36/185 , A23L1/30 , A61K36/756 , A61K36/254 , A61K36/55 , A61K36/258
CPC classification number: A61K31/34 , A23L33/105 , A23V2002/00 , A61K9/0014 , A61K9/0053 , A61K9/0095 , A61K9/1652 , A61K9/2059 , A61K36/00 , A61K36/185 , A61K36/254 , A61K36/258 , A61K36/55 , A61K36/756 , A23V2200/302 , A23V2200/326 , A23V2250/21
Abstract: The present invention discloses a composition for inhibiting vascular aging comprising a compound of Chemical formula 1, a derivative thereof or a pharmaceutically acceptable salt thereof as an active ingredient.
Abstract translation: 本发明公开了一种用于抑制血管衰老的组合物，其包含化学式1的化合物，其衍生物或其药学上可接受的盐作为活性成分。
-
-
-
-
-
-
-
-
Search Results
29
records
(took 0.02 seconds)
